Antenatal Milk Expression Education for Breastfeeding
(PREPARE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if teaching expectant mothers how to express milk before birth can improve breastfeeding success. It focuses on pregnant women with a higher body mass index (BMI ≥ 25), who often encounter challenges like low milk supply or early formula use. Participants will either receive remote lessons on antenatal milk expression (AME) or watch videos on infant care. Pregnant women who haven't given birth before and are interested in breastfeeding might be a good fit, especially if they are in their third trimester and have no diabetes.
As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance breastfeeding outcomes for many mothers.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that antenatal milk expression is safe for breastfeeding?
Research has shown that antenatal milk expression (AME) is generally safe for pregnant women. In a previous study, starting AME at week 34 did not trigger early labor, and no negative effects were reported. Most women in the study expressed milk several times a week without issues. This suggests that AME is well-tolerated and does not pose significant risks.12345
Why are researchers excited about this trial?
Researchers are excited about antenatal milk expression (AME) because it offers a proactive approach to breastfeeding preparation, potentially enhancing milk production before birth. Unlike traditional methods that focus on breastfeeding support post-delivery, AME involves weekly video interactions with lactation consultants, allowing expectant mothers to practice milk expression and collect any expressed milk during the final weeks of pregnancy. This method not only empowers mothers with hands-on skills but also aims to ease the early breastfeeding experience, potentially increasing breastfeeding success rates and boosting infant health from the start.
What evidence suggests that antenatal milk expression is effective for improving breastfeeding outcomes?
This trial will compare Antenatal Milk Expression (AME) with video-based infant care education. Studies have shown that expressing milk before birth, known as AME, can aid breastfeeding, particularly for women with higher body weight. Research indicates that AME can boost a mother's confidence in her ability to produce enough milk, addressing a common concern for new mothers. Early findings suggest that women using AME may achieve better breastfeeding success, even with conditions like diabetes. However, not all studies agree on its impact on the timing of milk production. Overall, AME is considered a promising method to support breastfeeding by addressing issues like low milk supply and the early need for formula.46789
Who Is on the Research Team?
Jill Demirci, PhD
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for first-time pregnant women with a BMI ≥ 25, interested in breastfeeding, between 34-36 weeks of pregnancy. They must plan to give birth at certain hospitals and speak English. Women with plans for early delivery, breast surgery history, or diabetes are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Antenatal Milk Expression (AME) Intervention
Weekly video interactions with lactation consultants to teach and reinforce antenatal milk expression, with at-home practice of hand expression and collection of expressed milk
Postpartum Follow-up
Participants are monitored for breastfeeding outcomes, including self-efficacy, exclusivity, and duration
What Are the Treatments Tested in This Trial?
Interventions
- AME
- Video-based infant care education
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator